Survival Trends for Cancer on the Increase Worldwide
Increasing trend seen for some lethal cancers, with up to 5 percent increase for liver, pancreas, lung CAs
Increasing trend seen for some lethal cancers, with up to 5 percent increase for liver, pancreas, lung CAs
Improved therapies and better screening has led to a plunge in breast cancer deaths over the last two decades.
[Cancer Management and Research] A comparison study evaluated whether radical hysterectomy or radiochemotherapy provides superior survival outcomes for patients with stage IB1 or IIA1 cervical cancer.
Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.
Patients with head and neck cancer treated at hospitals attaining the combined metric of a 90 percent or higher negative margin rate and 80% percent of cases achieving a LNY of 18 or more experienced a significant reduction in mortality.
Survival rate were worse for lower volume hospitals with higher quality scores, versus higher volume hospitals.
Complete surgical metastasectomy correlated with increased survival in patients with metastatic renal cell carcinoma (mRCC) compared with incomplete surgical metastasectomy.
The efficacy of imatinib for CML treatment persisted over time and long-term administration was not associated with unacceptable cumulative effects.
Nonadherence to NCCN guideline treatment recommendations was strongly associated with decreased survival from early-stage cervical cancer.
The site of cancer care may partially explain survival differences between children and AYAs with ALL.